Quantum BioPharma Ltd. (QNTM) is pleased to announce that after receiving approval from the Board of Directors, the Company has purchased USD $1,000,000 Bitcoin (BTC) and other cryptocurrencies as part of its strategic efforts. As well, going forward the Company will allow for future financing and other transactions to be carried out in cryptocurrency.
This move reflects the company’s belief in the potential of Bitcoin (BTC) and other currencies to provide a return on investment for shareholders. The company is now set up to receive financing in cryptocurrencies as well as executing other types of transactions in cryptocurrencies.
The company is holding all its cryptocurrency with a fully compliant custodian. The company emphasizes that all transactions are and will be fully compliant with all relevant financial and audit regulations, ensuring a secure and legal process.
The Company will continue to monitor market conditions and may increase or decrease its holdings of Bitcoin (BTC) or other cryptocurrencies as it deems appropriate.
“We are exploring innovative ways to grow our capital not being used in operations,” said Zeeshan Saeed, CEO of Quantum. “Bitcoin’s recent advancements in both legal and market legitimacy make it a compelling addition. With multiple global asset managers now offering BTC based exchange-traded funds, and renewed optimism following pro-crypto policy expectations under President-elect Donald Trump’s new administration, we believe Bitcoin (BTC), and other cryptocurrencies presents an opportunity to align with emerging financial trends.”
